Assessing treatment response to oral drugs for multiple sclerosis in real world setting: a MAGNIMS study

Ruggieri, S; Prosperini, L; Al-Araji, S; Annovazzi, P; Bisecco, A; Ciccarelli, O; De Stefano, N; Filippi, M; Fleischer, V; Evangelou, N; Enzinger, C; Gallo, A; Garjani, A; Groppa, S; Haggiag, S; Khalil, M; Lucchini, M; Mirabella, M; Montalban, X; Pozzilli, C; Preziosa, P; Rio, J; Rocca, MA; Rovira, A; Stromillo, ML; Zaffaroni, M; Tortorella, C; Gasperini, C

MULTIPLE SCLEROSIS JOURNAL, 2022; 28 (3_SUPPL): 657